Emsam

Product manufactured by Mylan Specialty L.p.

Application Nr Approved Date Route Status External Links
NDA021336 None Transdermal None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Emsam (Selegiline Transdermal System) Is A Monoamine Oxidase Inhibitor (Maoi) Indicated For The Treatment Of Adults With Major Depressive Disorder (Mdd) [See Clinical Studies (14) ] . Emsam ® (Selegiline Transdermal System) Is A Monoamine Oxidase Inhibitor (Maoi) Indicated For The Treatment Of Major Depressive Disorder (Mdd) ( 1 ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Selegiline SELEGILINE ZINC19632633

Comments